Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 35, 2014, Pages

  Khmaladze, Ia ^a   Kelkka, Tiina ^b,c,e   Guerard, Simon ^a   Wing, Kajsa ^a   Pizzolla, Angela ^a,f   Saxena, Amit ^a   Lundqvist, Katarina ^d   Holmdahl, Meirav ^d   Nandakumar, Kutty Selva ^a   Holmdahl, Rikard ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Turku Doctoral Programme of Biomedical Sciences   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Animal model; Autoimmune disease; Ncf1

Indexed keywords

ANIMAL MODEL; AUTOIMMUNE DISEASE; NCF1;

ANIMALS; ARTHRITIS, PSORIATIC; DERMATITIS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-17; JOINTS; MACROPHAGES; MANNANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MONOCYTES; NADPH OXIDASE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907228016     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1405798111     Document Type: Article

References (60)

1. Nickoloff BJ, Nestle FO (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113(12):1664-1675.
2. Liu Y, et al. (2008) A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 4(3):e1000041.
3. Tsoi LC, et al.; Collaborative Association Study of Psoriasis (CASP); Genetic Analysis of Psoriasis Consortium; Psoriasis Association Genetics Extension; Wellcome Trust Case Control Consortium 2 (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44(12):1341-1348.
4. Knight J, et al.; Wellcome Trust Case Control Consortium; Genetic Analysis of Psoriasis Consortium; I-chip for Psoriasis Consortium (2012) Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis. Hum Mol Genet 21(23):5185-5192.
5. Gladman DD, Farewell VT (2003) HLA studies in psoriatic arthritis: Current situation and future needs. J Rheumatol 30(1):4-6.
6. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370(9583):263-271.
7. Picciani BL, et al. (2013) Oral candidiasis in patients with psoriasis: Correlation of oral examination and cytopathological evaluation with psoriasis disease severity and treatment. J Am Acad Dermatol 68(6):986-991.
8. Bernotiene E, et al. (2004) Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice. Arthritis Res Ther 6(3):R256-R263.
9. van der Fits L, et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182(9):5836-5845.
10. Kumari S, et al. (2013) Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice. Immunity 39(5):899-911.
11. Maeda S, Hayami Y, Naniwa T, Ueda R (2012) The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis. Int J Rheumatol 2012:539683.
12. Ueyama A, et al. (2014) Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: A role for interferon-alpha in dendritic cell activation by imiquimod. J Dermatol 41(2):135-143.
13. Nishimoto S, et al. (2013) Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation. J Immunol 191(6):3065-3072.
14. Ariza ME, Williams MV, Wong HK (2013) Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application. Clin Immunol 146(2):131-139.
15. Hultqvist M, et al. (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 101(34):12646-12651.
16. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R (2011) NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal 15(8):2197-2208.
17. Holmdahl R, et al. (2013) Hydrogen peroxide as an immunological transmitter regulating autoreactive T cells. Antioxid Redox Signal 18(12):1463-1474.
18. Sareila O, Jaakkola N, Olofsson P, Kelkka T, Holmdahl R (2013) Identification of a region in p47phox/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation. J Leukoc Biol 93(3):427-435.
19. Raychaudhuri SP, Jiang WY, Raychaudhuri SK (2008) Revisiting the Koebner phenomenon: Role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol 172(4):961-971.
20. Forsberg E, et al. (1999) Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400(6746):773-776.
21. Kelkka T, Hultqvist M, Nandakumar KS, Holmdahl R (2012) Enhancement of antibody-induced arthritis via Toll-like receptor 2 stimulation is regulated by granulocyte reactive oxygen species. Am J Pathol 181(1):141-150.
22. Gelderman KA, et al. (2007) Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 117(10):3020-3028.
23. Chamberlain CS, et al. (2011) The influence of macrophage depletion on ligament healing. Connect Tissue Res 52(3):203-211.
24. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A (2010) IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 185(9):5453-5462.
25. Ryan C, Abramson A, Patel M, Menter A (2012) Current investigational drugs in psoriasis. Expert Opin Investig Drugs 21(4):473-487.
26. Zenz R, et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437(7057):369-375.
27. Bárdos T, Zhang J, Mikecz K, David CS, Glant TT (2002) Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age. Arthritis Rheum 46(9):2465-2475.
28. Wang H, et al. (2008) A 9-centimorgan interval of chromosome 10 controls the T cell-dependent psoriasiform skin disease and arthritis in a murine psoriasis model. J Immunol 180(8):5520-5529.
29. Gilliet M, et al. (2004) Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 140(12):1490-1495.
30. Wang H, et al. (2010) Extracellular adherence protein of Staphylococcus aureus suppresses disease by inhibiting T-cell recruitment in a mouse model of psoriasis. J Invest Dermatol 130(3):743-754.
31. Mease PJ (2011) Psoriatic arthritis: Update on pathophysiology, assessment and management. Ann Rheum Dis 70(Suppl 1):i77-i84.
32. Sagi L, Trau H (2011) The Koebner phenomenon. Clin Dermatol 29(2):231-236.
33. Zhou Q, Mrowietz U, Rostami-Yazdi M (2009) Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 47(7):891-905.
34. Foerster J, et al. (2006) Neutrophil respiratory burst is decreased in scleroderma and normalized by near-infrared mediated hyperthermia. Clin Exp Dermatol 31(6):799-806.
35. Kim HR, et al. (2014) Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function. PLoS ONE 9(3):e91146.
36. Olsson LM, et al. (2007) A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther 9(5):R98.
37. Deffert C, et al. (2012) Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells. J Pathol 228(3):341-350.
38. Hueber AJ, McInnes IB (2007) Immune regulation in psoriasis and psoriatic arthritis - Recent developments. Immunol Lett 114(2):59-65.
39. Ackermann L, et al. (1999) Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 140(4):624-633.
40. Wang Y, Rollins SA, Madri JA, Matis LA (1995) Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci USA 92(19):8955-8959.
41. Rosenberg EW, Noah PW, Wyatt RJ, Jones RM, Kolb WP (1990) Complement activation in psoriasis. Clin Exp Dermatol 15(1):16-20.
42. Stratis A, et al. (2006) Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 116(8):2094-2104.
43. Wang H, et al. (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 116(8):2105-2114.
44. Song C, et al. (2008) IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181(9):6117-6124.
45. Hashimoto M, et al. (2010) Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med 207(6):1135-1143.
46. Pantelyushin S, et al. (2012) Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122(6):2252-2256.
47. Garber K (2012) Anti-IL-17 mAbs herald new options in psoriasis. Nat Biotechnol 30(6):475-477.
48. Jouault T, et al. (2006) Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 177(7):4679-4687.
49. Nograles KE, et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159(5):1092-1102.
50. Homey B, et al. (2000) Up-regulation of macrophage inflammatory protein-3 alpha/ CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164(12):6621-6632.
51. Harper EG, et al. (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis. J Invest Dermatol 129(9):2175-2183.
52. Hedrick MN, et al. (2009) CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119(8):2317-2329.
53. Laggner U, et al. (2011) Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis. J Immunol 187(5):2783-2793.
54. Girardi M (2006) Immunosurveillance and immunoregulation by gammadelta T cells. J Invest Dermatol 126(1):25-31.
55. Mease PJ, et al. (2010) Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. J Rheumatol 37(6):1221-1227.
56. Ikeda S, et al. (2013) Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. J Am Acad Dermatol 68(4):609-617.
57. Pizzolla A, et al. (2012) Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections. J Immunol 188(10):5003-5011.
58. Lindqvist AK, et al. (2006) Backcross and partial advanced intercross analysis of nonobese diabetic gene-mediated effects on collagen-induced arthritis reveals an interactive effect by two major loci. J Immunol 177(6):3952-3959.
59. Holmdahl RCS, et al. (1998) Genetic analysis of murine models for rheumatoid arthritis. Human Genome Methods, ed Adolpho K (CRC, New York):pp 215-238.
60. Mabuchi T, et al. (2013) CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis. J Invest Dermatol 133(1):164-171.